Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marloes Prins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|July 23, 2015
Pathological differences between white and grey matter multiple sclerosis lesionsMarloes Prins, Emma Schul, Jeroen Geurts, et al.
Journal of Neuropathology and Experimental Neurology|May 18, 2019
Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis PatientsSvenja Kiljan, Marloes Prins, Bart M Baselmans, et al.
Progress in Neurobiology|June 27, 2012
Emerging roles of microglial activation and non-motor symptoms in Parkinson's diseaseKarlijn J Doorn, Paul J Lucassen, Hendrikus W Boddeke, et al.
Plos One|December 31, 2013
Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosisMarloes Prins, Charlotta Eriksson, Anne Wierinckx, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2011
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depressionNikoletta Dobos, Erik F J de Vries, Ido P Kema, et al.
Acta Neuropathologica Communications|August 24, 2014
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patientsMarloes Prins, Ranjan Dutta, Bart Baselmans, et al.
Acta Neuropathologica|June 22, 2011
Cholinergic imbalance in the multiple sclerosis hippocampusEvert-Jan Kooi, Marloes Prins, Natasha Bajic, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|July 23, 2015
Pathological differences between white and grey matter multiple sclerosis lesionsMarloes Prins, Emma Schul, Jeroen Geurts, et al.
Journal of Neuropathology and Experimental Neurology|May 18, 2019
Enhanced GABAergic Immunoreactivity in Hippocampal Neurons and Astroglia of Multiple Sclerosis PatientsSvenja Kiljan, Marloes Prins, Bart M Baselmans, et al.
Progress in Neurobiology|June 27, 2012
Emerging roles of microglial activation and non-motor symptoms in Parkinson's diseaseKarlijn J Doorn, Paul J Lucassen, Hendrikus W Boddeke, et al.
Plos One|December 31, 2013
Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosisMarloes Prins, Charlotta Eriksson, Anne Wierinckx, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2011
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depressionNikoletta Dobos, Erik F J de Vries, Ido P Kema, et al.
Acta Neuropathologica Communications|August 24, 2014
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patientsMarloes Prins, Ranjan Dutta, Bart Baselmans, et al.
Acta Neuropathologica|June 22, 2011
Cholinergic imbalance in the multiple sclerosis hippocampusEvert-Jan Kooi, Marloes Prins, Natasha Bajic, et al.
Pageof 1